AI Imaging Diagnostic Platform
Infectious Disease Diagnosis & Antibiotic Susceptibility Testing
Key Facts
About PhAST Diagnostics
PhAST Diagnostics is a private, pre-revenue company founded in 2019 that is developing an AI-powered diagnostic platform to address the global crisis of antimicrobial resistance (AMR). Its core technology combines single-cell imaging, microfluidics, and machine learning to rapidly identify pathogens and their antibiotic susceptibility, aiming to reduce diagnostic timelines from days to minutes. The company targets a three-pronged business model serving clinicians, hospitals, and pharma R&D, positioning itself at the intersection of AI diagnostics and infectious disease management. With a strong, multidisciplinary team and esteemed scientific advisors, PhAST is building a platform with significant potential impact on both clinical outcomes and public health.
View full company profile